BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19881518)

  • 21. Hormonal and cytokine implications in the pathophysiology of osteoporosis occurring in chronic liver diseases.
    Lucaci C; Acalovschi M
    Maedica (Bucur); 2012 Dec; 7(4):358-63. PubMed ID: 23483875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiology and pathomorphology of osteoporosis].
    Priemel M; Münch C; Beil FT; Ritzel H; Amling M
    Radiologe; 2006 Oct; 46(10):831-8. PubMed ID: 16964480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease.
    Ormarsdóttir S; Ljunggren O; Mallmin H; Brahm H; Lööf L
    J Hepatol; 1999 Jul; 31(1):84-90. PubMed ID: 10424287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Osteodystrophy: A Global (Re)View of the Problem.
    Barbu EC; Chițu-Tișu CE; Lazăr M; Olariu C; Bojincă M; Ionescu RA; Ion DA; Bădărău IA
    Acta Clin Croat; 2017 Sep; 56(3):512-525. PubMed ID: 29479918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholestasis and metabolic bone disease - a clinical review.
    Gasser RW
    Wien Med Wochenschr; 2008; 158(19-20):553-7. PubMed ID: 18998071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.
    Yang YJ; Kim DJ
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and management of osteoporosis in liver disease.
    Hay JE; Guichelaar MM
    Clin Liver Dis; 2005 Nov; 9(4):747-66, viii. PubMed ID: 16207574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation osteoporosis.
    Ebeling PR
    Curr Osteoporos Rep; 2007 Mar; 5(1):29-37. PubMed ID: 17320025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem.
    Carey EJ; Balan V; Kremers WK; Hay JE
    Liver Transpl; 2003 Nov; 9(11):1166-73. PubMed ID: 14586877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of bone disorders in liver disease.
    Parés A; Guañabens N
    J Hepatol; 2006 Sep; 45(3):445-53. PubMed ID: 16844255
    [No Abstract]   [Full Text] [Related]  

  • 32. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.
    Bongiovanni M; Tincati C
    Curr Mol Med; 2006 Jun; 6(4):395-400. PubMed ID: 16900662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of osteoporotic hip fractures.
    McClung MR
    Clin Cornerstone; 2003; Suppl 2():S22-9. PubMed ID: 15035556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise and osteoporosis.
    Sinaki M
    Arch Phys Med Rehabil; 1989 Mar; 70(3):220-9. PubMed ID: 2647057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased bone mineral density and periodontal management.
    Reddy MS; Morgan SL
    Periodontol 2000; 2013 Feb; 61(1):195-218. PubMed ID: 23240950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis.
    Ji JD; Woo JH; Choi SJ; Lee YH; Song GG
    Med Hypotheses; 2009 Aug; 73(2):201-2. PubMed ID: 19349124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density aspects in the femoral neck of hip fracture patients.
    Guerado E; Cruz E; Cano JR; Crespo PV; Alaminos M; Sánchez-Quevedo Mdel C; Campos A
    Injury; 2016 Jan; 47 Suppl 1():S21-4. PubMed ID: 26768284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease and osteoporosis.
    Sanchez AJ; Aranda-Michel J
    Nutr Clin Pract; 2006 Jun; 21(3):273-8. PubMed ID: 16772544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of Secondary Causes of Osteoporotic Fractures Due to Diabetes and Spinal Cord Injury.
    Zamarioli A; de Andrade Staut C; Volpon JB
    Curr Osteoporos Rep; 2020 Jun; 18(3):148-156. PubMed ID: 32147752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.